![Will Greenleaf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Will Greenleaf first degree
Entity | Entity type | Industry | |
---|---|---|---|
Epinomics, Inc.
![]() Epinomics, Inc. Packaged SoftwareTechnology Services Epinomics, Inc. provides decoding programming of genome to drive personalized medicine. The company was founded by Paul Giresi, Fergus Chan, Howard Y. Chang and Will Greenleaf and is headquartered in Menlo Park, CA.
3
| Subsidiary | Packaged Software | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Will Greenleaf via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Hemi Ventures LLC
![]() Hemi Ventures LLC Investment ManagersFinance Hemi Ventures LLC (Hemi Ventures) is a venture capital firm founded in 2016 by Amy Gu. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Accent Therapeutics, Inc.
![]() Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Founder | |
Cartography Biosciences, Inc.
![]() Cartography Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cartography Biosciences, Inc. is a biotech company that specializes in developing tumor-selective therapeutics using a unique genomics and computational platform. The company is based in Foster City, CA. The company integrates data from proprietary sample sourcing relationships, a comprehensive reference atlas, and target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography Biosciences is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. The company was founded by Ansuman Satpathy, Howard Y. Chang, Kevin Parker. Kevin Parker has been the CEO since incorporation. | Pharmaceuticals: Other | Founder | |
Orbital Therapeutics, Inc.
![]() Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder |
Statistics
International
United States | 5 |
Sectoral
Health Technology | 4 |
Finance | 2 |
Operational
Founder | 6 |
Corporate Secretary | 1 |
Chief Executive Officer | 1 |
Director of Finance/CFO | 1 |
Private Equity Investor | 1 |
Most connected contacts
Insiders | |
---|---|
Howard Y. Chang | 4 |
Fergus Chan | 2 |
Paul Giresi | 1 |
- Stock Market
- Insiders
- Will Greenleaf
- Company connections